Acorda Therapeutics | ACOR - Коммерческие и административные расходы



Коммерческие и административные расходы Изменить Дата
Acadia Pharmaceuticals USD 146.73M 21.82M 2025-12
Agios Pharmaceuticals USD 42.97M 1.7M 2025-12
ALKERMES USD 187.2M 15.43M 2025-12
Alterity Therapeutics Limited AUD 1.45M 703.96K 2025-12
Amgen USD 1.94B 237M 2025-12
Anika Therapeutics USD 10.01M 14K 2025-12
Arrowhead Research USD 46.02M 8.84M 2025-12
Biogen USD 545.2M 38.6M 2025-09
BioMarin Pharmaceutical USD 322.21M 98.79M 2025-12
Cara Therapeutics USD 2.19M 2.45M 2025-09
Cipla INR 13.25B 101.8M 2025-12
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.21M 120K 2025-12
CSL USD 1.23B 498M 2025-12
Cytokinetics USD 91.72M 67.02M 2025-12
Enanta Pharmaceuticals USD -1.05 0.31 2024-12
Gilead Sciences USD 1.78B 425M 2025-12
GlaxoSmithKline GBP 2.68B 518M 2025-12
Grifols EUR 320.45M 12.65M 2025-12
Halozyme Therapeutics USD 64.64M 27.11M 2025-12
Heron Therapeutics USD 23.74M 605K 2025-12
Insmed USD 212.48M 26.11M 2025-12
Ligand Pharmaceuticals USD 28.45M 8.27M 2025-09
MannKind USD 29.09M 2.53M 2025-09
Merck EUR 1.6B 136M 2025-12
Moderna USD 308M 40M 2025-12
Neurocrine Biosciences USD 301.8M 10.2M 2025-12
Novartis USD 3.44B 128M 2025-12
Pfizer USD 4.08B 894M 2025-12
Sanofi EUR 2.75B 455M 2025-12
Teva Pharmaceutical Industries USD 1.12B 147M 2025-12
Ultragenyx Pharmaceutical USD 89M 2.38M 2025-12
Vertex Pharmaceuticals USD 487M 41.9M 2025-12